NIIC User vs NBIR Device Tracking

With over 100 years of EMS, Medical Services, Fire Fighting & IT experience, Blaster Communications Inc. has created NIIC (Narcotic Identification Inventory Control). NIIC is a mobile App designed for both iPhones and iPads. It is designed to help Fire Stations, Hospitals, Pharmacies and EMS staffs track narcotics & prevent diversion to help manage victims after a major disaster or emergency. Our system has proven to be accurate and extremely user friendly in streamlining the communication and easing the day-to-day operations of field and administrative staffs. The User App primarily utilizes iPhones. Each User logs into the User App with the assigned User ID and Password provided by the Administrator to access an incident to begin assessing and administering narcotics to victims. Below are the additional features : • QR/Bar code technology to create accounts for Administrative & Field Staff. • All data is stored in the CLOUD, Data-Centers & or Servers. It operates using Wi-Fi, Cellular Signal, the Internet or Intranet. • Chain of Responsibility tracks the narcotic inventory from Manufacturer’s Lot number, all the way to the use/waste stage using QR/Bar code technology. • Daily reports and notifications on narcotic usage, breakage, waste and expiration are sent to headquarters. • Unit to Unit/User to User releasing or responsibility functions. • Four levels of security: Digital Signature, Picture Identification, QR/Bar Code Scans & Visual Counts. • One step mail merging of all Staff information from Desktop Computer to App. • Works in conjunction with Narcotic Tamper Evident Bags that ensure an efficient narcotic accountability system due to regulations of Local, State, and Federal Laws.

The NBIR Device Tracking App is a HIPAA-compliant app that can be used to quickly capture data that is required for the purposes of device tracking – a federally-mandated requirement of manufacturers of breast implants. This means physicians can simultaneously fulfill their device tracking requirements for Allergan, Mentor and Sientra by participating in the NBIR. The app uses OCR technology to scan and capture data from patient demographic forms and breast implant device barcodes. Captured data is securely packaged in a case report form and submitted to NBIR. The NBIR is a collaboration between The Plastic Surgery Foundation, the FDA, and breast implant device manufacturers for the purpose of strengthening the post-market surveillance infrastructure for current and future breast implant devices. For more information, please visit thepsf.org/NBIR